Michael Retsky, principal of ELOPT, received a PhD in physics from
University of Chicago in 1974. In addition to his physics activities, he also has a part time appointment as Lecturer in Surgery
in the late Judah Folkman's Vascular Biology Department at Harvard Medical School.
A particular interest in medical research is the impact of surgery
on tumor dormancy in breast cancer. Links and recent papers are contained in cancer research pages. This project
benefited initially from a Phase I SBIR grant from NIH to make an expert system for breast cancer.
Michael and collaborators have had four invited reviews on breast cancer
in 2007 including a paper in Nature - Clinical Practice of Oncology. His research has resulted in several press releases from
Harvard Medical School and has been discussed in Wall Street Journal, Boston Globe, Baltimore Sun, and a number of popular
websites. ELOPT has benefited from five grants including a phase I SBIR from NIH (different from the one mentioned